Pharmacovigilance
Pharmacovigilance
| Product | Date | Safety information | Attachments |
|---|---|---|---|
| Ecalta (Anidulafungin) | 2020-03-11 | Ecalta 100mg Powder for Concentrate for Solution for Infusion (Anidulafungin): Solution for Infusion must no longer be frozen |
|
| Depakine (Valproate) | 2020-02-01 | Restrictions on use; pregnancy prevention programme to be put in place. |
|
| Kyprolis® ( Carfilzomib) | 2019-12-12 | Kyprolis (carfilzomib) – New Safety Information: Risk of Progressive Multifocal Leukoencephalopathy (PML) and Hepatitis B Virus (HBV) Reactivation |
|
| Esbriet® (Pirfenidone) | 2019-12-08 | Important Safety Update on ESBRIET® (pirfenidone) and Drug-Induced Liver Injury (DILI) |
|
| Arava® -leflunomide | 2019-09-25 | Risk of serious birth defects when administered during pregnancy |
|
| Fingolimod (Gilenya®) | 2016-03-21 | Risks related to the effects on the immune system . |
|
| Xarelto ® (Rivaroxaban) | 2015-12-14 | Warnings and precautions for use to reduce the risk of bleeding.
|
|
| Motilium® (Domperidone) | 2014-09-22 | New recommendations to minimise the cardiac risks . |
|
| Amistop® (Domperidone) | 2014-09-14 | New recommendations to minimise the cardiac risks . |
|
| Mododom® (Domperidone) | 2014-09-14 | New recommendations to minimise the cardiac risks . |
|